Home-sampling in Partner Notification of Chlamydia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01596946|
Recruitment Status : Completed
First Posted : May 11, 2012
Last Update Posted : May 11, 2012
|Condition or disease||Intervention/treatment|
|Chlamydia||Behavioral: Contact tracing mode test at clinic Behavioral: Self-sampling at home - Sent Test Kit|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||633 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Home-sampling as a Tool in a Chlamydia Trachomatis Partner Notification Context. A Multi-centre Cluster-randomized Controlled Trial.|
|Study Start Date :||November 2006|
|Primary Completion Date :||October 2011|
|Study Completion Date :||November 2011|
Active Comparator: Contact tracing mode test at clinic
Conventional mode of contact tracing where the partners were asked by either the index patient or demanded by the counsellor to attend a clinic for C. trachomatis testing. The date of testing for chlamydia of the study subject i e a sexual partner to a chlamydia infected index patient was noted. Those partners being C trachomatis positive were referred to the STD-clinic for contact tracing and following the same study arm a the index patient.
|Behavioral: Contact tracing mode test at clinic|
Experimental: Self-sampling at home
The intervention: Self-sampling of sexual partners to infected index patient for chlamydia by urine test or vaginal sampling at home. They sent the kit tube to a microbiological laboratorium for analysis. The test kit was sent by post by the counsellor at the STD-clinic or distributed via the index patient. The partner in this arm was informed about the test result from the STD-clinic and those tested C trachomatis positive were given an appointment for treating and contact tracing as soon as possible. Their partners were not randomised but following the same mode. The days from the counselling conversation with the index patient to the date of testing was measured and compared with partners tested following arm 1 mode.
|Behavioral: Self-sampling at home - Sent Test Kit|
- Difference in time, measured as days from the meeting between the index patient and the counsellor (i.e. the eliciting of sexually partners) until the date of C. trachomatis testing of partners [ Time Frame: 60 days or more were defined as an exclusion criterion ]Difference in time, measured as days from the meeting between the index patient and the counsellor (i.e. the eliciting of sexually partners) until the date of C. trachomatis testing of partners, if sexual partners had attended a clinic for testing or had the opportunity of home-sampling.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01596946
|R&D department of Local Health Care|
|Linköping, Sweden, 581 85|
|Principal Investigator:||Lars Falk, MD PhD||Östergötland CC|